...
首页> 外文期刊>Biochimica et biophysica acta. Biomembranes >Imaging mass spectrometry (IMS) of cortical lipids from preclinical to severe stages of Alzheimer's disease
【24h】

Imaging mass spectrometry (IMS) of cortical lipids from preclinical to severe stages of Alzheimer's disease

机译:从阿尔茨海默病的临床前到严重阶段的皮质脂质的成像质谱(IMS)

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Abstract Alzheimer's disease (AD) is a progressive neurodegenerative disease affecting millions of patients worldwide. Previous studies have demonstrated alterations in the lipid composition of lipid extracts from plasma and brain samples of AD patients. However, there is no consensus regarding the qualitative and quantitative changes of lipids in brains from AD patients. In addition, the recent developments in imaging mass spectrometry methods are leading to a new stage in the in situ analysis of lipid species in brain tissue slices from human postmortem samples. The present study uses the matrix-assisted laser desorption/ionization imaging mass spectrometry (MALDI-IMS), permitting the direct anatomical analysis of lipids in postmortem brain sections from AD patients, which are compared with the intensity of the lipid signal in samples from matched subjects with no neurological diseases. The frontal cortex samples from AD patients were classified in three groups based on Braak's histochemical criteria, ranging from non-cognitively impaired patients to those severely affected. The main results indicate a depletion of different sulfatide lipid species from the earliest stages of the disease in both white and gray matter areas of the frontal cortex. Therefore, the decrease in sulfatides in cortical areas could be considered as a marker of the disease, but may also indicate neurochemical modifications related to the pathogenesis of the disease. This article is part of a Special Issue entitled: Membrane Lipid Therapy: Drugs Targeting Biomembranes edited by Pablo V. Escribá. Graphical abstract Display Omitted Highlights ? Lipid IMS in AD patients shows modulation of different lipid species between AD and age-matched control patients. ? High decrease of ST relative intensity in AD patients compared with age-matched controls. ? ST decrease could be related with axon deregulation leading to synaptic dysfunction. ]]>
机译:摘要阿尔茨海默病(AD)是一种影响全球数百万患者的进步神经退行性疾病。以前的研究表明,来自AD患者的血浆和脑样品的脂质组合物的脂质组合物的改变。但是,来自AD患者的血脂中脂质的定性和定量变化没有共识。此外,近期成像质谱法的发展导致来自人类后术样品的脑组织切片中的脂质种类的原位分析新的阶段。本研究采用基质辅助激光解吸/电离成像质谱(MALDI-IMS),允许来自AD患者的后模脑切片中脂质的直接解剖分析,其与来自匹配的样品中的样品中的脂质信号的强度进行比较没有神经疾病的受试者。来自AD患者的正面皮质样品在基于BRAAK的组织化学标准的三组分类,从非认知障碍患者到严重受影响的组织化学标准。主要结果表明,在额叶的白色和灰质地区的最早疾病中,不同硫酸脂质物种的耗竭。因此,皮质区域中的硫酸酯的降低可以被认为是疾病的标志物,但也可能表明与疾病的发病机制有关的神经化学修饰。本文是标题的特殊问题的一部分:膜脂质疗法:靶向PabloV.Scribá编辑的生物膜的药物。图形抽象显示省略了亮点? AD患者的脂质IMS显示出AD和年龄匹配对照患者之间不同脂质种类的调节。还与年龄匹配的对照相比,AD患者中的ST相对强度降低。还ST减少可能与导致突触功能障碍的轴突放松管制有关。 ]]>

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号